Key facts
| Price (PPV) | 45.10 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | ipratropium |
| Class | Drugs for obstructive airway diseases |
| ATC code | R03BB01 |
| Manufacturer | BOTTU S.A. |
| Presentation | 10 récipients unidoses |
| Nature | Médicament |
| Hospital price | 28.20 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement symptomatique des asthmes aigus graves de l’enfant, en association avec un bêta2 mimétique d'action rapide. Remarque : l'asthme aigu grave nécessite une hospitalisation en milieu spécialisé. Une oxygénothérapie et une corticothérapie par voie systémique doivent être associées au traitement bronchodilatateur.
Find an open pharmacy
On-call pharmacies near you
About Atrovent Enfant 0.25 mg / 2 ml
Atrovent Enfant 0.25 mg / 2 ml belongs to the drugs for obstructive airway diseases therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Atrovent Enfant 0.25 mg / 2 ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Atrovent Enfant 0.25 mg / 2 ml
Answers to common questions from Moroccan patients about this drug.